Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90,825 | -314,670 | -226,385 | -149,248 | -66,166 |
| Depreciation Amortization | 1,319 | 6,421 | 4,803 | 3,258 | 1,754 |
| Accounts receivable | -1,064 | 2,438 | 1,397 | 44 | -6,379 |
| Accounts payable and accrued liabilities | -4,469 | 5,329 | 742 | 4,930 | -994 |
| Other Working Capital | -24,016 | -24,832 | -24,364 | -10,034 | -20,436 |
| Other Operating Activity | 20,055 | 40,082 | 33,029 | 17,987 | 18,147 |
| Operating Cash Flow | $-99,000 | $-285,232 | $-210,778 | $-133,063 | $-74,074 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,432 | -4,627 | -3,347 | -1,328 | -293 |
| Purchase Of Investment | -330,971 | -688,702 | -604,525 | -468,556 | -26,740 |
| Sale Of Investment | 164,871 | 635,421 | 508,116 | 303,711 | 136,585 |
| Investing Cash Flow | $-167,532 | $-57,908 | $-99,756 | $-166,173 | $109,552 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 528,465 | 284,472 | 282,610 | 277,095 | 4,146 |
| Other Financing Activity | -188 | 638 | -89 | 104 | -100 |
| Financing Cash Flow | $528,277 | $285,110 | $282,521 | $277,199 | $4,046 |
| Beginning Cash Position | 102,724 | 160,754 | 160,754 | 160,754 | 160,754 |
| End Cash Position | 364,469 | 102,724 | 132,741 | 138,717 | 200,278 |
| Net Cash Flow | $261,745 | $-58,030 | $-28,013 | $-22,037 | $39,524 |
| Free Cash Flow | |||||
| Operating Cash Flow | -99,000 | -285,232 | -210,778 | -133,063 | -74,074 |
| Capital Expenditure | -1,432 | -4,627 | -3,347 | -1,328 | -293 |
| Free Cash Flow | -100,432 | -289,859 | -214,125 | -134,391 | -74,367 |